Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Walmart DRC | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | $874.83B | 41x | 3.74 | $34.80 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
George Weston | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $63.55B | 24.5x | -0.93 | $219.82 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.9% Upside | Upgrade to Pro+ | |
George Weston Ser 3 Prf | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $63.55B | 24.5x | -0.93 | $22.02 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
George Weston 5.20 Ser Iv Prf | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $63.55B | 24.5x | -0.93 | $22.05 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
George Weston Prf | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $63.55B | 24.5x | -0.93 | $24.37 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
George Weston 4.75 Ser V Prf | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $63.55B | 24.5x | $20.39 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
George Weston | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | $63.55B | 24.5x | 63.2 | $219.83 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Loblaw Companies | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $53.28B | 26.1x | 3.36 | $175.41 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5% Upside | Upgrade to Pro+ | |
Loblaw Companies | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $53.28B | 26.1x | 3.36 | $23.29 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Metro Inc. | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $18.52B | 20.2x | $83.10 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.4% Upside | Upgrade to Pro+ | ||
Empire Company | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $9.67B | 14.9x | -1.98 | $40.69 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.3% Upside | Upgrade to Pro+ | |
Green Thumb | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $3.26B | 36.6x | 0.08 | $13.81 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
North West | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $2.51B | 1.88 | $51.83 | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Verano Holdings | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | $1.61B | -10.8x | -0.17 | $4.39 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Terrascend | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $594.94M | -1.1x | -0.06 | $1.69 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Terrascend | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $594.94M | -1.1x | -0.06 | $1.69 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Glass House Brands | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | $342M | -10.1x | -0.45 | $11.98 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Planet 13 | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $259.96M | -1.9x | 0.95 | $0.81 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Planet 13 | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $259.96M | -1.9x | 0.95 | $0.81 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
High Tide | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | $246.06M | -7.9x | -0.15 | $3.06 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CareRx | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $130.39M | -18.1x | -2.47 | $2.17 | 3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Colabor Group Inc. | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $122.42M | 36.4x | -0.78 | $1.20 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nova Cannabis | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $107.40M | 32.8x | 0.24 | $1.73 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Marimed | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $78.02M | -3.3x | 0.01 | $0.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PharmaCorp Rx | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | $76.02M | -60.3x | 0.98 | $0.66 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gold Flora | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | $34.30M | -0.5x | -0.02 | $0.10 | -8.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CordovaCann | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $10.98M | -2x | 0.06 | $0.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
DAVIDsTEA | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | $10.25M | -0.9x | -0.05 | $0.39 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CanadaBis Capital | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | $7.60M | 3.4x | -0.12 | $0.05 | -8.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Im Cannabis | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $6.90M | -0.5x | -0.01 | $3 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |